Pages that link to "Q22250892"

The following pages link to Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin (Q22250892):

Displaying 50 items.

• The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome (Q21093273) (← links)
• Intention to lose weight, weight changes, and 18-y mortality in overweight individuals without co-morbidities (Q21144722) (← links)
• Case-based study: from prediabetes to complications--opportunities for prevention (Q21144738) (← links)
• Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan (Q21245262) (← links)
• A comprehensive review on metabolic syndrome (Q21284500) (← links)
• The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases (Q21296864) (← links)
• Intentional weight loss and dose reductions of anti-diabetic medications--a retrospective cohort study (Q21560863) (← links)
• A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue (Q21563356) (← links)
• The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors (Q21563399) (← links)
• Erectile dysfunction and central obesity: an Italian perspective (Q22241096) (← links)
• Role of insulin in the type 2 diabetes therapy: past, present and future (Q22241148) (← links)
• American Cancer Society guidelines on nutrition and physical activity for cancer prevention (Q22241237) (← links)
• Use of metformin in the setting of mild-to-moderate renal insufficiency (Q22241290) (← links)
• 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. (Q22241393) (← links)
• Metformin: new understandings, new uses (Q22241434) (← links)
• Oral Antidiabetic Agents (Q22241436) (← links)
• The management of gestational diabetes (Q22241441) (← links)
• ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary (Q22241786) (← links)
• Metformin -- life begins at 50: A symposium held on the occasion of the 43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam, The Netherlands, September 2007 (Q22241787) (← links)
• Management of Obesity in Adults: European Clinical Practice Guidelines (Q22241943) (← links)
• Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications (Q22242884) (← links)
• Metformin and body weight (Q22250988) (← links)
• The oral glucose tolerance test (OGTT) revisited (Q22252223) (← links)
• Obesity and the skin: Skin physiology and skin manifestations of obesity (Q22252420) (← links)
• Long-term drug treatment for obesity: a systematic and clinical review (Q22253010) (← links)
• Diagnosis and classification of diabetes mellitus (Q22255452) (← links)
• Diagnosis and Classification of Diabetes Mellitus (Q22255454) (← links)
• The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes (Q22306221) (← links)
• Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association (Q22306331) (← links)
• Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association (Q22306345) (← links)
• Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (Q22306384) (← links)
• Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness (Q22306395) (← links)
• The state of US health, 1990-2010: burden of diseases, injuries, and risk factors (Q23909354) (← links)
• Applying RE-AIM to the evaluation of FUEL Your Life: a worksite translation of DPP (Q23909875) (← links)
• Clinically significant weight gain 1 year after occupational back injury (Q23910365) (← links)
• A walking program for outpatients in psychiatric rehabilitation: pilot study (Q23915528) (← links)
• Physical activity and body mass index: the contribution of age and workplace characteristics (Q24169773) (← links)
• Dipeptidyl-peptidase (DPP)-4 inhibitors or glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus (Q24185805) (← links)
• Interventions for the prevention of type 2 diabetes mellitus in women with previous gestational diabetes (Q24185836) (← links)
• Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus (Q24185874) (← links)
• Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus (Q24185970) (← links)
• Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for development of type 2 diabetes mellitus (Q24186087) (← links)
• Acupuncture for adults with type 2 diabetes mellitus (Q24186271) (← links)
• Diet and exercise interventions for preventing gestational diabetes mellitus (Q24186535) (← links)
• Dietary advice for the prevention of type 2 diabetes mellitus in adults (Q24186597) (← links)
• Theory-based behavioural interventions for prediabetic state and people with diabetes mellitus (Q24186851) (← links)
• Lifestyle interventions for the treatment of urinary incontinence in adults (Q24187247) (← links)
• Group based diabetes self-management education compared to routine treatment, waiting list control or no intervention for people with type 2 diabetes mellitus (Q24187367) (← links)
• Metformin monotherapy for type 2 diabetes mellitus (Q24187392) (← links)
• Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries (Q24188028) (← links)